ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR21

At the Foot of the Hemodialysis Room: Online Hemodiafiltration and High-Flux Hemodialysis, a Multicenter Study

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Martinez Vaquera, Shaira, Diaverum Espana, Madrid, Spain
  • Gil, Antoni Bordils, Diaverum Espana, Madrid, Spain
  • Useche Bonilla, Gustavo Andres, Diaverum Espana, Madrid, Spain
  • Alfaro Sanchez, Christian Israel, Diaverum Espana, Madrid, Spain
  • Pizarro Leon, Jose Luis, Diaverum Espana, Madrid, Spain
Background

Several studies highlight the relevance of convective transport versus diffusive transport in the elimination of substances of higher molecular weight with great advantages in the prevention of chronic complications. Convective techniques improve them substantially. Among them, on-line hemodiafiltration (HDF-OL) is the one that eliminates more medium and high molecular weight toxins, although high-flux hemodialysis with high permeability dialyzers comes close to the advantages offered by HDF-OL. The aim of the present study is to estimate whether there are differences in the different parameters between high-flux hemodialysis (HD-FH) and OL-HDF.

Methods

Multicenter, retrospective, descriptive study, analyzing the evolution in one year in both techniques. Variables of interest: demographics, Charlson comorbidity index, Karnofsky index, analytical parameters (urea kinetics, nutrition, inflammation, bone-mineral metabolism, anemia, dyslipidemia), interdialysis weight gain, diabetes, arterial hypertension and hospitalization among others.

Results

A total of 1674 in OL-HDF and 889 in HD-HF. No differences in: sex, diabetes, etiology of nephropathy, physical activity, smoking, months on dialysis, dry weight, interdialysis gain. There were statistically significant differences in favor of OL-HDF in: KtV, ß2-microglobulin, hemoglobin levels and PTH. In favor of HDF-HF-HDF: albumin and aluminum. The proportion of hospitalized patients was higher in the OL-HDF group (41%) compared to the high-flow HD group (37%) (p 0.044).

Conclusion

These results highlight the complexity of choosing the optimal dialysis technique, which must be customized according to the patient's specific needs and clinical situation. Although OL-HDF offers advantages in the removal of larger toxins, which is crucial to prevent chronic complications, the observed hospitalization rate suggests the need for vigilance.

Funding

  • Other NIH Support